CytoMed Therapeutics Ltd - GDTC
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Axiom Investment Management LLC | History | New | 7,032 | 7 | 0.0% | — | 1 | +7,032 | New | Q2 2026 | Jul 30, 2026 |
| UBS Group AG | History | Reduced | 4,831 | 4 | 0.0% | 0.0% | 2 | -1,351 | -21.85% | Q2 2026 | Aug 13, 2026 |
| XTX Topco Ltd | History | Closed out | 0 | 0 | — | 0.0% | — | -10,136 | -100.0% | Q2 2026 | Aug 14, 2026 |
| OSAIC HOLDINGS, INC. | History | No change | 21 | 0 | — | — | — | 0 | 0.0% | Q2 2026 | Aug 14, 2026 |